HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:
Guest Access | Sign In via User Name/Password

This Article Full Text Free Full Text (PDF) Free Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Article Archive Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (23) Citing Articles via Google Scholar Google Scholar Articles by Corbelli, R. Articles by Hammer, J. Search for Related Content PubMed PubMed Citation Articles by Corbelli, R. Articles by Hammer, J.

Nasal Nitric Oxide Measurements To Screen Children for Primary Ciliary Dyskinesia^*

^* From the Division of Intensive Care and Pulmonology (Drs. Corbelli, Bringolf-Isler, Amacher, and Hammer), University Children’s Hospital Basel, Basel; and Electron Microscopy Laboratory (Drs. Sasse and Spycher), Department of Pathology, University Hospital Zürich, Switzerland.

Correspondence to: Jürg Hammer, MD, Division of Intensive Care and Pulmonology, University Children’s Hospital Basel, Römergasse 8, 4005 Basel, Switzerland; e-mail: juerg.hammer{at}unibas.ch

Study objective: To examine the usefulness of exhaled and nasal nitric oxide (NO) measurements to detect primary ciliary dyskinesia (PCD) in children.

Design and methods: The study population consisted of 34 children with symptoms suggestive of PCD who were previously referred to our pediatric university respiratory disease clinic for a diagnostic workup including analysis of ciliary structure and function by respiratory mucosal biopsy. PCD was diagnosed in 17 of the 34 children according to the ciliary biopsy results. Measurements of nasal and exhaled NO were performed according to European Respiratory Society and American Thoracic Society guidelines in the patients with and without biopsy-proven PCD, and also in 24 healthy age-matched subjects.

Results: Nasal NO was significantly lower in those children with proven PCD (geometric mean; 13.7 parts per billion [ppb]), compared to those who had negative biopsy results (132.7 ppb) and healthy control subjects (223.7 ppb). The measurement of nasal NO in our study population showed, below a cut-off level of < 105 ppb, a specificity of 88% for PCD, and positive predictive value of 89%. Nasal NO above a cut-off level of 105 ppb excluded PCD with a 100% certainty. The lower levels of exhaled NO in patients with PCD did not reach statistical significance.

Conclusion: The measurement of nasal NO appears to be a useful tool to screen children for PCD and to exclude this disease in those with high nasal NO levels.

Key Words: bronchiectasis • bronchitis • children • exhaled nitric oxide • Kartagener syndrome • nasal nitric oxide • primary ciliary dyskinesia • situs inversus

This article has been cited by other articles:

				J. K. Marthin, J. Mortensen, T. Pressler, and K. G. Nielsen Pulmonary Radioaerosol Mucociliary Clearance in Diagnosis of Primary Ciliary Dyskinesia Chest, September 1, 2007; 132(3): 966 - 976. [Abstract] [Full Text] [PDF]

				M. Pifferi, D. Caramella, A. M. Cangiotti, V. Ragazzo, P. Macchia, and A. L. Boner Nasal Nitric Oxide in Atypical Primary Ciliary Dyskinesia Chest, March 1, 2007; 131(3): 870 - 873. [Abstract] [Full Text] [PDF]

				B. Degano, M. Genestal, E. Serrano, J. Rami, and J.-F. Arnal Effect of Treatment on Maxillary Sinus and Nasal Nitric Oxide Concentrations in Patients With Nosocomial Maxillary Sinusitis Chest, September 1, 2005; 128(3): 1699 - 1705. [Abstract] [Full Text] [PDF]